NCT02313155View on ClinicalTrials.gov

Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Influenza Infection
Interventions
DRUG

Subcutaneous injection of TAK-850

TAK-850 0.5 mL, Subcutaneous injection

DRUG

Intramuscular injection of TAK-850

TAK-850 0.5 mL, Intramuscular injection

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY